Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19.
Sorrentino L, Silvestri V, Oliveto G, Scordio M, Frasca F, Fracella M, Bitossi C, D'Auria A, Santinelli L, Gabriele L, Pierangeli A, Mastroianni CM, d'Ettorre G, Antonelli G, Caruz A, Ottini L, Scagnolari C. Sorrentino L, et al. Among authors: caruz a. Microorganisms. 2022 Feb 4;10(2):363. doi: 10.3390/microorganisms10020363. Microorganisms. 2022. PMID: 35208821 Free PMC article.
Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
Barreiro P, Pineda JA, Rallón N, Naggie S, Martín-Carbonero L, Neukam K, Rivero A, Benito JM, Caruz A, Vispo E, Camacho A, Medrano J, McHutchison J, Soriano V. Barreiro P, et al. Among authors: caruz a. J Infect Dis. 2011 Jun 1;203(11):1629-36. doi: 10.1093/infdis/jir113. J Infect Dis. 2011. PMID: 21592993
Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.
Neukam K, Nattermann J, Rallón N, Rivero A, Caruz A, Macías J, Vogel M, Benito J, Camacho A, Mira J, Schwarze-Zander C, Barreiro P, Martínez A, Rockstroh J, Soriano V, Pineda J. Neukam K, et al. Among authors: caruz a. HIV Med. 2011 Sep;12(8):487-93. doi: 10.1111/j.1468-1293.2011.00912.x. Epub 2011 Mar 6. HIV Med. 2011. PMID: 21375685 Free article.
Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients.
Rivero-Juárez A, Lopez-Cortes LF, Camacho A, Torres-Cornejo A, Pineda JA, Marquez-Solero M, Caruz A, Ruiz-Valderas R, Torre-Cisneros J, Gutierrez-Valencia A, Rivero A. Rivero-Juárez A, et al. Among authors: caruz a. PLoS One. 2012;7(11):e48959. doi: 10.1371/journal.pone.0048959. Epub 2012 Nov 8. PLoS One. 2012. PMID: 23145040 Free PMC article. Clinical Trial.
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.
Medrano J, Neukam K, Rallón N, Rivero A, Resino S, Naggie S, Caruz A, Calvino A, Macías J, Benito JM, Sánchez-Piedra C, Vispo E, Barreiro P, McHutchison J, Pineda JA, Soriano V. Medrano J, et al. Among authors: caruz a. Clin Infect Dis. 2010 Nov 15;51(10):1209-16. doi: 10.1086/656811. Clin Infect Dis. 2010. PMID: 20964522
74 results